Clinical Trial Update: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study [Phase 2]

View source ↗

Summary

This clinical trial update reports that the Phase 2 study evaluating liraglutide for psoriatic arthritis (and related conditions) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Psoriasis
• Psoriatic Arthritis
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Psoriatic Arthritis, Psoriasis | Phase 2 | Status: WITHDRAWN